ConductScience.org, home
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension
API referenceFor AI assistants

Trial · NCT02867813

Adverse events1,940

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,940

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherBronchitisInfections and infestationsPlacebo in Parent Study1622,532
otherBronchitisInfections and infestationsEvolocumab in Parent Study1732,499
otherNasopharyngitisInfections and infestationsPlacebo in Parent Study1572,532
otherNasopharyngitisInfections and infestationsEvolocumab in Parent Study1562,499
otherUpper respiratory tract infectionInfections and infestationsPlacebo in Parent Study2082,532
otherUpper respiratory tract infectionInfections and infestationsEvolocumab in Parent Study1622,499
otherDiabetes mellitusMetabolism and nutrition disordersPlacebo in Parent Study1392,532
otherDiabetes mellitusMetabolism and nutrition disordersEvolocumab in Parent Study1352,499
otherArthralgiaMusculoskeletal and connective tissue disordersPlacebo in Parent Study1442,532
otherArthralgiaMusculoskeletal and connective tissue disordersEvolocumab in Parent Study1382,499
otherBack painMusculoskeletal and connective tissue disordersPlacebo in Parent Study1332,532
otherBack painMusculoskeletal and connective tissue disordersEvolocumab in Parent Study1372,499
otherHypertensionVascular disordersPlacebo in Parent Study3272,532
otherHypertensionVascular disordersEvolocumab in Parent Study3552,499
seriousAgranulocytosisBlood and lymphatic system disordersPlacebo in Parent Study02,532
seriousAgranulocytosisBlood and lymphatic system disordersEvolocumab in Parent Study12,499
seriousAnaemiaBlood and lymphatic system disordersPlacebo in Parent Study132,532
seriousAnaemiaBlood and lymphatic system disordersEvolocumab in Parent Study182,499
seriousAnaemia macrocyticBlood and lymphatic system disordersPlacebo in Parent Study12,532
seriousAnaemia macrocyticBlood and lymphatic system disordersEvolocumab in Parent Study02,499

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02867813/events

API referenceFor AI assistants